Bent, Rebekka; Moll, Lorna; Grabbe, Stephan et al.
Interleukin-1 Beta-A Friend or Foe in Malignancies?INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 19. H. 8. 2018
Saloga, Joachim; Grabbe, Stephan
Invitation to the DGAKI Spring ConferenceALLERGO JOURNAL. Bd. 27. H. 7. 2018 S. 72-72
Kaehler, Katharina C.; Eigentler, Thomas K.; Gesierich, Anja et al.
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disordersCANCER IMMUNOLOGY IMMUNOTHERAPY. Bd. 67. H. 5. 2018 S. 825-834
Schmitt, J.; Haufe, E.; Trautmann, F. et al.
Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181BRITISH JOURNAL OF DERMATOLOGY. Bd. 178. H. 2. 2018 S. 462-472
Straub, B. K.; Ridder, D. A.; Schad, A. et al.
Liver injury induced by immune checkpoint inhibitor-therapy. Example of an immune-mediated drug side effectPATHOLOGE. Bd. 39. H. 6. 2018 S. 556-562
Lear, J. T.; Migden, M. R.; Lewis, K. D. et al.
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT studyJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. Bd. 32. H. 3. 2018 S. 372-381
Schmidberger, Heinz; Rapp, Matthias; Ebersberger, Anne et al.
Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence mattersSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 194. H. 12. 2018 S. 1144-1151
Lang, B. M.; Peveling-Oberhag, A.; Faidt, D. et al.
Long-term survival with modern therapeutic agents against metastatic melanoma-vemurafenib and ipilimumab in a daily life settingMEDICAL ONCOLOGY. Bd. 35. H. 3. 2018
Wagner, Nicola; Staubach, Petra
Mastocytosis - pathogenesis, clinical manifestation and treatmentJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 16. H. 1. 2018 S. 42-56
Jappe, U.; Minge, S.; Kreft, B. et al.
Meat allergy associated with galactosyl--(1,3)-galactose (-Gal)Closing diagnostic gaps by anti--Gal IgE immune profilingALLERGY. Bd. 73. H. 1. 2018 S. 93-105